Global Digital Genome

Digital Genome Comprehensive Study by Application (Microbiology {Biological, Clinical, Industrial}, Reproductive & Genetic, Transplantation, Livestock and Agriculture, Forensics, Research and Development), End Users (Diagnostics & Forensic Labs, Academic Research Institutes, Hospitals, Bio-Pharmaceutical Companies), Technology (Sequencing, Microarray, PCR), Product (Sequencing & Analyzer Instruments, DNA/RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sample Preparation Instruments) Players and Region - Global Market Outlook to 2028

Digital Genome Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The Digital genome is a combined set of genetic material that happens in a cell or an organism. It is the easiest method to collect chronic diseases and used by professionals to get a nearer look of genetic disorders. The major growth factor in this industry is the growing consciousness of genetic roles incidence of chronic disorders across the globe. Additionally, there are many factors impacting on the development of genetic disorders. Along with the increasing number of drug inventions and other genomics researchThis growth is primarily driven by Increasing Demand for the Open Access Web-Based Database of Medically Relevant Genomic Variants .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitK Units
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Health Care Facilities sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Umbel (United States), NanoString (United States), BiogeniQ (Canada), GenomeMe (Canada), Illumina (United States), Agilent Technologies Inc. (United States), BioMerieux (France), Becton (United States), Dickinson and Company (United States) and F. Hoffmann-La Roche Ltd. (Switzerland), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In May, 2022, AMP Agency, a full-service digital marketing agency, has acquired Genome, an award-winning digital innovation, transformation and product development company. The addition of Genome will further AMP Agency's strategy to advance technology-enabled innovation and grow internationally.
In October 2019, Inscripta, a digital genome engineering firm, revealed the launch of the Onyx, a digital genome engineering platform. This is a completely automated benchtop device to perform genome level work. This platform provides major benefits to healthcare and genome discovery.The companies operating in this sector are concentrating more on efficient growth, upgrading operational efficiency and productivity, realizing high safety standards, and focus on maintaining sustainable development. The players are focusing on securing the leading position in this industry. They are uninterruptedly observing for the prospect to reinforce their economic advantage. To meet a high market share, and developing socially responsible business companies are identifying various strategic initiatives such as mergers & acquisitions, new product launch, product enhancement, and others.

Influencing Trend:
The Emergence of New Players in the Market and Increasing Number of Strategic Initiative by Leading Players across the Industry

Market Growth Drivers:
Increasing Demand for the Open Access Web-Based Database of Medically Relevant Genomic Variants, Increase the Prevalence of NHGRI for DNA Analysis and Uprising of Biotechnology

Challenges:
High Cost Associated with Genomic Equipment

Restraints:
Lack of Skilled Professionals

Opportunities:
Advancement of Healthcare Infrastructure in Asia Pacific Regions

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Digital Genome Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Digital Genome Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Digital Genome players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Digital Genome Study Sheds Light on
— The Digital Genome Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Digital Genome industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Digital Genome industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • Microbiology {Biological, Clinical, Industrial}
  • Reproductive & Genetic
  • Transplantation
  • Livestock and Agriculture
  • Forensics
  • Research and Development
By End Users
  • Diagnostics & Forensic Labs
  • Academic Research Institutes
  • Hospitals
  • Bio-Pharmaceutical Companies

By Technology
  • Sequencing
  • Microarray
  • PCR

By Product
  • Sequencing & Analyzer Instruments
  • DNA/RNA Analysis Kits
  • Sequencing Chips
  • Sequencing & Analysis Software
  • Sample Preparation Instruments

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Demand for the Open Access Web-Based Database of Medically Relevant Genomic Variants
      • 3.2.2. Increase the Prevalence of NHGRI for DNA Analysis
      • 3.2.3. Uprising of Biotechnology
    • 3.3. Market Challenges
      • 3.3.1. High Cost Associated with Genomic Equipment
    • 3.4. Market Trends
      • 3.4.1. The Emergence of New Players in the Market
      • 3.4.2. Increasing Number of Strategic Initiative by Leading Players across the Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Digital Genome, by Application, End Users, Technology, Product and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Digital Genome (Value)
      • 5.2.1. Global Digital Genome by: Application (Value)
        • 5.2.1.1. Microbiology {Biological, Clinical, Industrial}
        • 5.2.1.2. Reproductive & Genetic
        • 5.2.1.3. Transplantation
        • 5.2.1.4. Livestock and Agriculture
        • 5.2.1.5. Forensics
        • 5.2.1.6. Research and Development
      • 5.2.2. Global Digital Genome by: End Users (Value)
        • 5.2.2.1. Diagnostics & Forensic Labs
        • 5.2.2.2. Academic Research Institutes
        • 5.2.2.3. Hospitals
        • 5.2.2.4. Bio-Pharmaceutical Companies
      • 5.2.3. Global Digital Genome by: Technology (Value)
        • 5.2.3.1. Sequencing
        • 5.2.3.2. Microarray
        • 5.2.3.3. PCR
      • 5.2.4. Global Digital Genome by: Product (Value)
        • 5.2.4.1. Sequencing & Analyzer Instruments
        • 5.2.4.2. DNA/RNA Analysis Kits
        • 5.2.4.3. Sequencing Chips
        • 5.2.4.4. Sequencing & Analysis Software
        • 5.2.4.5. Sample Preparation Instruments
      • 5.2.5. Global Digital Genome Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Digital Genome (Volume)
      • 5.3.1. Global Digital Genome by: Application (Volume)
        • 5.3.1.1. Microbiology {Biological, Clinical, Industrial}
        • 5.3.1.2. Reproductive & Genetic
        • 5.3.1.3. Transplantation
        • 5.3.1.4. Livestock and Agriculture
        • 5.3.1.5. Forensics
        • 5.3.1.6. Research and Development
      • 5.3.2. Global Digital Genome by: End Users (Volume)
        • 5.3.2.1. Diagnostics & Forensic Labs
        • 5.3.2.2. Academic Research Institutes
        • 5.3.2.3. Hospitals
        • 5.3.2.4. Bio-Pharmaceutical Companies
      • 5.3.3. Global Digital Genome by: Technology (Volume)
        • 5.3.3.1. Sequencing
        • 5.3.3.2. Microarray
        • 5.3.3.3. PCR
      • 5.3.4. Global Digital Genome by: Product (Volume)
        • 5.3.4.1. Sequencing & Analyzer Instruments
        • 5.3.4.2. DNA/RNA Analysis Kits
        • 5.3.4.3. Sequencing Chips
        • 5.3.4.4. Sequencing & Analysis Software
        • 5.3.4.5. Sample Preparation Instruments
      • 5.3.5. Global Digital Genome Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Digital Genome (Price)
  • 6. Digital Genome: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Umbel (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. NanoString (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BiogeniQ (Canada)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GenomeMe (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Illumina (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Agilent Technologies Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioMerieux (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Becton (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Dickinson and Company (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Digital Genome Sale, by Application, End Users, Technology, Product and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Digital Genome (Value)
      • 7.2.1. Global Digital Genome by: Application (Value)
        • 7.2.1.1. Microbiology {Biological, Clinical, Industrial}
        • 7.2.1.2. Reproductive & Genetic
        • 7.2.1.3. Transplantation
        • 7.2.1.4. Livestock and Agriculture
        • 7.2.1.5. Forensics
        • 7.2.1.6. Research and Development
      • 7.2.2. Global Digital Genome by: End Users (Value)
        • 7.2.2.1. Diagnostics & Forensic Labs
        • 7.2.2.2. Academic Research Institutes
        • 7.2.2.3. Hospitals
        • 7.2.2.4. Bio-Pharmaceutical Companies
      • 7.2.3. Global Digital Genome by: Technology (Value)
        • 7.2.3.1. Sequencing
        • 7.2.3.2. Microarray
        • 7.2.3.3. PCR
      • 7.2.4. Global Digital Genome by: Product (Value)
        • 7.2.4.1. Sequencing & Analyzer Instruments
        • 7.2.4.2. DNA/RNA Analysis Kits
        • 7.2.4.3. Sequencing Chips
        • 7.2.4.4. Sequencing & Analysis Software
        • 7.2.4.5. Sample Preparation Instruments
      • 7.2.5. Global Digital Genome Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Digital Genome (Volume)
      • 7.3.1. Global Digital Genome by: Application (Volume)
        • 7.3.1.1. Microbiology {Biological, Clinical, Industrial}
        • 7.3.1.2. Reproductive & Genetic
        • 7.3.1.3. Transplantation
        • 7.3.1.4. Livestock and Agriculture
        • 7.3.1.5. Forensics
        • 7.3.1.6. Research and Development
      • 7.3.2. Global Digital Genome by: End Users (Volume)
        • 7.3.2.1. Diagnostics & Forensic Labs
        • 7.3.2.2. Academic Research Institutes
        • 7.3.2.3. Hospitals
        • 7.3.2.4. Bio-Pharmaceutical Companies
      • 7.3.3. Global Digital Genome by: Technology (Volume)
        • 7.3.3.1. Sequencing
        • 7.3.3.2. Microarray
        • 7.3.3.3. PCR
      • 7.3.4. Global Digital Genome by: Product (Volume)
        • 7.3.4.1. Sequencing & Analyzer Instruments
        • 7.3.4.2. DNA/RNA Analysis Kits
        • 7.3.4.3. Sequencing Chips
        • 7.3.4.4. Sequencing & Analysis Software
        • 7.3.4.5. Sample Preparation Instruments
      • 7.3.5. Global Digital Genome Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Digital Genome (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Digital Genome: by Application(USD Million)
  • Table 2. Digital Genome Microbiology {Biological, Clinical, Industrial} , by Region USD Million (2017-2022)
  • Table 3. Digital Genome Reproductive & Genetic , by Region USD Million (2017-2022)
  • Table 4. Digital Genome Transplantation , by Region USD Million (2017-2022)
  • Table 5. Digital Genome Livestock and Agriculture , by Region USD Million (2017-2022)
  • Table 6. Digital Genome Forensics , by Region USD Million (2017-2022)
  • Table 7. Digital Genome Research and Development , by Region USD Million (2017-2022)
  • Table 8. Digital Genome: by End Users(USD Million)
  • Table 9. Digital Genome Diagnostics & Forensic Labs , by Region USD Million (2017-2022)
  • Table 10. Digital Genome Academic Research Institutes , by Region USD Million (2017-2022)
  • Table 11. Digital Genome Hospitals , by Region USD Million (2017-2022)
  • Table 12. Digital Genome Bio-Pharmaceutical Companies , by Region USD Million (2017-2022)
  • Table 13. Digital Genome: by Technology(USD Million)
  • Table 14. Digital Genome Sequencing , by Region USD Million (2017-2022)
  • Table 15. Digital Genome Microarray , by Region USD Million (2017-2022)
  • Table 16. Digital Genome PCR , by Region USD Million (2017-2022)
  • Table 17. Digital Genome: by Product(USD Million)
  • Table 18. Digital Genome Sequencing & Analyzer Instruments , by Region USD Million (2017-2022)
  • Table 19. Digital Genome DNA/RNA Analysis Kits , by Region USD Million (2017-2022)
  • Table 20. Digital Genome Sequencing Chips , by Region USD Million (2017-2022)
  • Table 21. Digital Genome Sequencing & Analysis Software , by Region USD Million (2017-2022)
  • Table 22. Digital Genome Sample Preparation Instruments , by Region USD Million (2017-2022)
  • Table 23. South America Digital Genome, by Country USD Million (2017-2022)
  • Table 24. South America Digital Genome, by Application USD Million (2017-2022)
  • Table 25. South America Digital Genome, by End Users USD Million (2017-2022)
  • Table 26. South America Digital Genome, by Technology USD Million (2017-2022)
  • Table 27. South America Digital Genome, by Product USD Million (2017-2022)
  • Table 28. Brazil Digital Genome, by Application USD Million (2017-2022)
  • Table 29. Brazil Digital Genome, by End Users USD Million (2017-2022)
  • Table 30. Brazil Digital Genome, by Technology USD Million (2017-2022)
  • Table 31. Brazil Digital Genome, by Product USD Million (2017-2022)
  • Table 32. Argentina Digital Genome, by Application USD Million (2017-2022)
  • Table 33. Argentina Digital Genome, by End Users USD Million (2017-2022)
  • Table 34. Argentina Digital Genome, by Technology USD Million (2017-2022)
  • Table 35. Argentina Digital Genome, by Product USD Million (2017-2022)
  • Table 36. Rest of South America Digital Genome, by Application USD Million (2017-2022)
  • Table 37. Rest of South America Digital Genome, by End Users USD Million (2017-2022)
  • Table 38. Rest of South America Digital Genome, by Technology USD Million (2017-2022)
  • Table 39. Rest of South America Digital Genome, by Product USD Million (2017-2022)
  • Table 40. Asia Pacific Digital Genome, by Country USD Million (2017-2022)
  • Table 41. Asia Pacific Digital Genome, by Application USD Million (2017-2022)
  • Table 42. Asia Pacific Digital Genome, by End Users USD Million (2017-2022)
  • Table 43. Asia Pacific Digital Genome, by Technology USD Million (2017-2022)
  • Table 44. Asia Pacific Digital Genome, by Product USD Million (2017-2022)
  • Table 45. China Digital Genome, by Application USD Million (2017-2022)
  • Table 46. China Digital Genome, by End Users USD Million (2017-2022)
  • Table 47. China Digital Genome, by Technology USD Million (2017-2022)
  • Table 48. China Digital Genome, by Product USD Million (2017-2022)
  • Table 49. Japan Digital Genome, by Application USD Million (2017-2022)
  • Table 50. Japan Digital Genome, by End Users USD Million (2017-2022)
  • Table 51. Japan Digital Genome, by Technology USD Million (2017-2022)
  • Table 52. Japan Digital Genome, by Product USD Million (2017-2022)
  • Table 53. India Digital Genome, by Application USD Million (2017-2022)
  • Table 54. India Digital Genome, by End Users USD Million (2017-2022)
  • Table 55. India Digital Genome, by Technology USD Million (2017-2022)
  • Table 56. India Digital Genome, by Product USD Million (2017-2022)
  • Table 57. South Korea Digital Genome, by Application USD Million (2017-2022)
  • Table 58. South Korea Digital Genome, by End Users USD Million (2017-2022)
  • Table 59. South Korea Digital Genome, by Technology USD Million (2017-2022)
  • Table 60. South Korea Digital Genome, by Product USD Million (2017-2022)
  • Table 61. Taiwan Digital Genome, by Application USD Million (2017-2022)
  • Table 62. Taiwan Digital Genome, by End Users USD Million (2017-2022)
  • Table 63. Taiwan Digital Genome, by Technology USD Million (2017-2022)
  • Table 64. Taiwan Digital Genome, by Product USD Million (2017-2022)
  • Table 65. Australia Digital Genome, by Application USD Million (2017-2022)
  • Table 66. Australia Digital Genome, by End Users USD Million (2017-2022)
  • Table 67. Australia Digital Genome, by Technology USD Million (2017-2022)
  • Table 68. Australia Digital Genome, by Product USD Million (2017-2022)
  • Table 69. Rest of Asia-Pacific Digital Genome, by Application USD Million (2017-2022)
  • Table 70. Rest of Asia-Pacific Digital Genome, by End Users USD Million (2017-2022)
  • Table 71. Rest of Asia-Pacific Digital Genome, by Technology USD Million (2017-2022)
  • Table 72. Rest of Asia-Pacific Digital Genome, by Product USD Million (2017-2022)
  • Table 73. Europe Digital Genome, by Country USD Million (2017-2022)
  • Table 74. Europe Digital Genome, by Application USD Million (2017-2022)
  • Table 75. Europe Digital Genome, by End Users USD Million (2017-2022)
  • Table 76. Europe Digital Genome, by Technology USD Million (2017-2022)
  • Table 77. Europe Digital Genome, by Product USD Million (2017-2022)
  • Table 78. Germany Digital Genome, by Application USD Million (2017-2022)
  • Table 79. Germany Digital Genome, by End Users USD Million (2017-2022)
  • Table 80. Germany Digital Genome, by Technology USD Million (2017-2022)
  • Table 81. Germany Digital Genome, by Product USD Million (2017-2022)
  • Table 82. France Digital Genome, by Application USD Million (2017-2022)
  • Table 83. France Digital Genome, by End Users USD Million (2017-2022)
  • Table 84. France Digital Genome, by Technology USD Million (2017-2022)
  • Table 85. France Digital Genome, by Product USD Million (2017-2022)
  • Table 86. Italy Digital Genome, by Application USD Million (2017-2022)
  • Table 87. Italy Digital Genome, by End Users USD Million (2017-2022)
  • Table 88. Italy Digital Genome, by Technology USD Million (2017-2022)
  • Table 89. Italy Digital Genome, by Product USD Million (2017-2022)
  • Table 90. United Kingdom Digital Genome, by Application USD Million (2017-2022)
  • Table 91. United Kingdom Digital Genome, by End Users USD Million (2017-2022)
  • Table 92. United Kingdom Digital Genome, by Technology USD Million (2017-2022)
  • Table 93. United Kingdom Digital Genome, by Product USD Million (2017-2022)
  • Table 94. Netherlands Digital Genome, by Application USD Million (2017-2022)
  • Table 95. Netherlands Digital Genome, by End Users USD Million (2017-2022)
  • Table 96. Netherlands Digital Genome, by Technology USD Million (2017-2022)
  • Table 97. Netherlands Digital Genome, by Product USD Million (2017-2022)
  • Table 98. Rest of Europe Digital Genome, by Application USD Million (2017-2022)
  • Table 99. Rest of Europe Digital Genome, by End Users USD Million (2017-2022)
  • Table 100. Rest of Europe Digital Genome, by Technology USD Million (2017-2022)
  • Table 101. Rest of Europe Digital Genome, by Product USD Million (2017-2022)
  • Table 102. MEA Digital Genome, by Country USD Million (2017-2022)
  • Table 103. MEA Digital Genome, by Application USD Million (2017-2022)
  • Table 104. MEA Digital Genome, by End Users USD Million (2017-2022)
  • Table 105. MEA Digital Genome, by Technology USD Million (2017-2022)
  • Table 106. MEA Digital Genome, by Product USD Million (2017-2022)
  • Table 107. Middle East Digital Genome, by Application USD Million (2017-2022)
  • Table 108. Middle East Digital Genome, by End Users USD Million (2017-2022)
  • Table 109. Middle East Digital Genome, by Technology USD Million (2017-2022)
  • Table 110. Middle East Digital Genome, by Product USD Million (2017-2022)
  • Table 111. Africa Digital Genome, by Application USD Million (2017-2022)
  • Table 112. Africa Digital Genome, by End Users USD Million (2017-2022)
  • Table 113. Africa Digital Genome, by Technology USD Million (2017-2022)
  • Table 114. Africa Digital Genome, by Product USD Million (2017-2022)
  • Table 115. North America Digital Genome, by Country USD Million (2017-2022)
  • Table 116. North America Digital Genome, by Application USD Million (2017-2022)
  • Table 117. North America Digital Genome, by End Users USD Million (2017-2022)
  • Table 118. North America Digital Genome, by Technology USD Million (2017-2022)
  • Table 119. North America Digital Genome, by Product USD Million (2017-2022)
  • Table 120. United States Digital Genome, by Application USD Million (2017-2022)
  • Table 121. United States Digital Genome, by End Users USD Million (2017-2022)
  • Table 122. United States Digital Genome, by Technology USD Million (2017-2022)
  • Table 123. United States Digital Genome, by Product USD Million (2017-2022)
  • Table 124. Canada Digital Genome, by Application USD Million (2017-2022)
  • Table 125. Canada Digital Genome, by End Users USD Million (2017-2022)
  • Table 126. Canada Digital Genome, by Technology USD Million (2017-2022)
  • Table 127. Canada Digital Genome, by Product USD Million (2017-2022)
  • Table 128. Mexico Digital Genome, by Application USD Million (2017-2022)
  • Table 129. Mexico Digital Genome, by End Users USD Million (2017-2022)
  • Table 130. Mexico Digital Genome, by Technology USD Million (2017-2022)
  • Table 131. Mexico Digital Genome, by Product USD Million (2017-2022)
  • Table 132. Digital Genome Sales: by Application(K Units)
  • Table 133. Digital Genome Sales Microbiology {Biological, Clinical, Industrial} , by Region K Units (2017-2022)
  • Table 134. Digital Genome Sales Reproductive & Genetic , by Region K Units (2017-2022)
  • Table 135. Digital Genome Sales Transplantation , by Region K Units (2017-2022)
  • Table 136. Digital Genome Sales Livestock and Agriculture , by Region K Units (2017-2022)
  • Table 137. Digital Genome Sales Forensics , by Region K Units (2017-2022)
  • Table 138. Digital Genome Sales Research and Development , by Region K Units (2017-2022)
  • Table 139. Digital Genome Sales: by End Users(K Units)
  • Table 140. Digital Genome Sales Diagnostics & Forensic Labs , by Region K Units (2017-2022)
  • Table 141. Digital Genome Sales Academic Research Institutes , by Region K Units (2017-2022)
  • Table 142. Digital Genome Sales Hospitals , by Region K Units (2017-2022)
  • Table 143. Digital Genome Sales Bio-Pharmaceutical Companies , by Region K Units (2017-2022)
  • Table 144. Digital Genome Sales: by Technology(K Units)
  • Table 145. Digital Genome Sales Sequencing , by Region K Units (2017-2022)
  • Table 146. Digital Genome Sales Microarray , by Region K Units (2017-2022)
  • Table 147. Digital Genome Sales PCR , by Region K Units (2017-2022)
  • Table 148. Digital Genome Sales: by Product(K Units)
  • Table 149. Digital Genome Sales Sequencing & Analyzer Instruments , by Region K Units (2017-2022)
  • Table 150. Digital Genome Sales DNA/RNA Analysis Kits , by Region K Units (2017-2022)
  • Table 151. Digital Genome Sales Sequencing Chips , by Region K Units (2017-2022)
  • Table 152. Digital Genome Sales Sequencing & Analysis Software , by Region K Units (2017-2022)
  • Table 153. Digital Genome Sales Sample Preparation Instruments , by Region K Units (2017-2022)
  • Table 154. South America Digital Genome Sales, by Country K Units (2017-2022)
  • Table 155. South America Digital Genome Sales, by Application K Units (2017-2022)
  • Table 156. South America Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 157. South America Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 158. South America Digital Genome Sales, by Product K Units (2017-2022)
  • Table 159. Brazil Digital Genome Sales, by Application K Units (2017-2022)
  • Table 160. Brazil Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 161. Brazil Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 162. Brazil Digital Genome Sales, by Product K Units (2017-2022)
  • Table 163. Argentina Digital Genome Sales, by Application K Units (2017-2022)
  • Table 164. Argentina Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 165. Argentina Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 166. Argentina Digital Genome Sales, by Product K Units (2017-2022)
  • Table 167. Rest of South America Digital Genome Sales, by Application K Units (2017-2022)
  • Table 168. Rest of South America Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 169. Rest of South America Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 170. Rest of South America Digital Genome Sales, by Product K Units (2017-2022)
  • Table 171. Asia Pacific Digital Genome Sales, by Country K Units (2017-2022)
  • Table 172. Asia Pacific Digital Genome Sales, by Application K Units (2017-2022)
  • Table 173. Asia Pacific Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 174. Asia Pacific Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 175. Asia Pacific Digital Genome Sales, by Product K Units (2017-2022)
  • Table 176. China Digital Genome Sales, by Application K Units (2017-2022)
  • Table 177. China Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 178. China Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 179. China Digital Genome Sales, by Product K Units (2017-2022)
  • Table 180. Japan Digital Genome Sales, by Application K Units (2017-2022)
  • Table 181. Japan Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 182. Japan Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 183. Japan Digital Genome Sales, by Product K Units (2017-2022)
  • Table 184. India Digital Genome Sales, by Application K Units (2017-2022)
  • Table 185. India Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 186. India Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 187. India Digital Genome Sales, by Product K Units (2017-2022)
  • Table 188. South Korea Digital Genome Sales, by Application K Units (2017-2022)
  • Table 189. South Korea Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 190. South Korea Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 191. South Korea Digital Genome Sales, by Product K Units (2017-2022)
  • Table 192. Taiwan Digital Genome Sales, by Application K Units (2017-2022)
  • Table 193. Taiwan Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 194. Taiwan Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 195. Taiwan Digital Genome Sales, by Product K Units (2017-2022)
  • Table 196. Australia Digital Genome Sales, by Application K Units (2017-2022)
  • Table 197. Australia Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 198. Australia Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 199. Australia Digital Genome Sales, by Product K Units (2017-2022)
  • Table 200. Rest of Asia-Pacific Digital Genome Sales, by Application K Units (2017-2022)
  • Table 201. Rest of Asia-Pacific Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 202. Rest of Asia-Pacific Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 203. Rest of Asia-Pacific Digital Genome Sales, by Product K Units (2017-2022)
  • Table 204. Europe Digital Genome Sales, by Country K Units (2017-2022)
  • Table 205. Europe Digital Genome Sales, by Application K Units (2017-2022)
  • Table 206. Europe Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 207. Europe Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 208. Europe Digital Genome Sales, by Product K Units (2017-2022)
  • Table 209. Germany Digital Genome Sales, by Application K Units (2017-2022)
  • Table 210. Germany Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 211. Germany Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 212. Germany Digital Genome Sales, by Product K Units (2017-2022)
  • Table 213. France Digital Genome Sales, by Application K Units (2017-2022)
  • Table 214. France Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 215. France Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 216. France Digital Genome Sales, by Product K Units (2017-2022)
  • Table 217. Italy Digital Genome Sales, by Application K Units (2017-2022)
  • Table 218. Italy Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 219. Italy Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 220. Italy Digital Genome Sales, by Product K Units (2017-2022)
  • Table 221. United Kingdom Digital Genome Sales, by Application K Units (2017-2022)
  • Table 222. United Kingdom Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 223. United Kingdom Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 224. United Kingdom Digital Genome Sales, by Product K Units (2017-2022)
  • Table 225. Netherlands Digital Genome Sales, by Application K Units (2017-2022)
  • Table 226. Netherlands Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 227. Netherlands Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 228. Netherlands Digital Genome Sales, by Product K Units (2017-2022)
  • Table 229. Rest of Europe Digital Genome Sales, by Application K Units (2017-2022)
  • Table 230. Rest of Europe Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 231. Rest of Europe Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 232. Rest of Europe Digital Genome Sales, by Product K Units (2017-2022)
  • Table 233. MEA Digital Genome Sales, by Country K Units (2017-2022)
  • Table 234. MEA Digital Genome Sales, by Application K Units (2017-2022)
  • Table 235. MEA Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 236. MEA Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 237. MEA Digital Genome Sales, by Product K Units (2017-2022)
  • Table 238. Middle East Digital Genome Sales, by Application K Units (2017-2022)
  • Table 239. Middle East Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 240. Middle East Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 241. Middle East Digital Genome Sales, by Product K Units (2017-2022)
  • Table 242. Africa Digital Genome Sales, by Application K Units (2017-2022)
  • Table 243. Africa Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 244. Africa Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 245. Africa Digital Genome Sales, by Product K Units (2017-2022)
  • Table 246. North America Digital Genome Sales, by Country K Units (2017-2022)
  • Table 247. North America Digital Genome Sales, by Application K Units (2017-2022)
  • Table 248. North America Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 249. North America Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 250. North America Digital Genome Sales, by Product K Units (2017-2022)
  • Table 251. United States Digital Genome Sales, by Application K Units (2017-2022)
  • Table 252. United States Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 253. United States Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 254. United States Digital Genome Sales, by Product K Units (2017-2022)
  • Table 255. Canada Digital Genome Sales, by Application K Units (2017-2022)
  • Table 256. Canada Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 257. Canada Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 258. Canada Digital Genome Sales, by Product K Units (2017-2022)
  • Table 259. Mexico Digital Genome Sales, by Application K Units (2017-2022)
  • Table 260. Mexico Digital Genome Sales, by End Users K Units (2017-2022)
  • Table 261. Mexico Digital Genome Sales, by Technology K Units (2017-2022)
  • Table 262. Mexico Digital Genome Sales, by Product K Units (2017-2022)
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Company Basic Information, Sales Area and Its Competitors
  • Table 272. Company Basic Information, Sales Area and Its Competitors
  • Table 273. Digital Genome: by Application(USD Million)
  • Table 274. Digital Genome Microbiology {Biological, Clinical, Industrial} , by Region USD Million (2023-2028)
  • Table 275. Digital Genome Reproductive & Genetic , by Region USD Million (2023-2028)
  • Table 276. Digital Genome Transplantation , by Region USD Million (2023-2028)
  • Table 277. Digital Genome Livestock and Agriculture , by Region USD Million (2023-2028)
  • Table 278. Digital Genome Forensics , by Region USD Million (2023-2028)
  • Table 279. Digital Genome Research and Development , by Region USD Million (2023-2028)
  • Table 280. Digital Genome: by End Users(USD Million)
  • Table 281. Digital Genome Diagnostics & Forensic Labs , by Region USD Million (2023-2028)
  • Table 282. Digital Genome Academic Research Institutes , by Region USD Million (2023-2028)
  • Table 283. Digital Genome Hospitals , by Region USD Million (2023-2028)
  • Table 284. Digital Genome Bio-Pharmaceutical Companies , by Region USD Million (2023-2028)
  • Table 285. Digital Genome: by Technology(USD Million)
  • Table 286. Digital Genome Sequencing , by Region USD Million (2023-2028)
  • Table 287. Digital Genome Microarray , by Region USD Million (2023-2028)
  • Table 288. Digital Genome PCR , by Region USD Million (2023-2028)
  • Table 289. Digital Genome: by Product(USD Million)
  • Table 290. Digital Genome Sequencing & Analyzer Instruments , by Region USD Million (2023-2028)
  • Table 291. Digital Genome DNA/RNA Analysis Kits , by Region USD Million (2023-2028)
  • Table 292. Digital Genome Sequencing Chips , by Region USD Million (2023-2028)
  • Table 293. Digital Genome Sequencing & Analysis Software , by Region USD Million (2023-2028)
  • Table 294. Digital Genome Sample Preparation Instruments , by Region USD Million (2023-2028)
  • Table 295. South America Digital Genome, by Country USD Million (2023-2028)
  • Table 296. South America Digital Genome, by Application USD Million (2023-2028)
  • Table 297. South America Digital Genome, by End Users USD Million (2023-2028)
  • Table 298. South America Digital Genome, by Technology USD Million (2023-2028)
  • Table 299. South America Digital Genome, by Product USD Million (2023-2028)
  • Table 300. Brazil Digital Genome, by Application USD Million (2023-2028)
  • Table 301. Brazil Digital Genome, by End Users USD Million (2023-2028)
  • Table 302. Brazil Digital Genome, by Technology USD Million (2023-2028)
  • Table 303. Brazil Digital Genome, by Product USD Million (2023-2028)
  • Table 304. Argentina Digital Genome, by Application USD Million (2023-2028)
  • Table 305. Argentina Digital Genome, by End Users USD Million (2023-2028)
  • Table 306. Argentina Digital Genome, by Technology USD Million (2023-2028)
  • Table 307. Argentina Digital Genome, by Product USD Million (2023-2028)
  • Table 308. Rest of South America Digital Genome, by Application USD Million (2023-2028)
  • Table 309. Rest of South America Digital Genome, by End Users USD Million (2023-2028)
  • Table 310. Rest of South America Digital Genome, by Technology USD Million (2023-2028)
  • Table 311. Rest of South America Digital Genome, by Product USD Million (2023-2028)
  • Table 312. Asia Pacific Digital Genome, by Country USD Million (2023-2028)
  • Table 313. Asia Pacific Digital Genome, by Application USD Million (2023-2028)
  • Table 314. Asia Pacific Digital Genome, by End Users USD Million (2023-2028)
  • Table 315. Asia Pacific Digital Genome, by Technology USD Million (2023-2028)
  • Table 316. Asia Pacific Digital Genome, by Product USD Million (2023-2028)
  • Table 317. China Digital Genome, by Application USD Million (2023-2028)
  • Table 318. China Digital Genome, by End Users USD Million (2023-2028)
  • Table 319. China Digital Genome, by Technology USD Million (2023-2028)
  • Table 320. China Digital Genome, by Product USD Million (2023-2028)
  • Table 321. Japan Digital Genome, by Application USD Million (2023-2028)
  • Table 322. Japan Digital Genome, by End Users USD Million (2023-2028)
  • Table 323. Japan Digital Genome, by Technology USD Million (2023-2028)
  • Table 324. Japan Digital Genome, by Product USD Million (2023-2028)
  • Table 325. India Digital Genome, by Application USD Million (2023-2028)
  • Table 326. India Digital Genome, by End Users USD Million (2023-2028)
  • Table 327. India Digital Genome, by Technology USD Million (2023-2028)
  • Table 328. India Digital Genome, by Product USD Million (2023-2028)
  • Table 329. South Korea Digital Genome, by Application USD Million (2023-2028)
  • Table 330. South Korea Digital Genome, by End Users USD Million (2023-2028)
  • Table 331. South Korea Digital Genome, by Technology USD Million (2023-2028)
  • Table 332. South Korea Digital Genome, by Product USD Million (2023-2028)
  • Table 333. Taiwan Digital Genome, by Application USD Million (2023-2028)
  • Table 334. Taiwan Digital Genome, by End Users USD Million (2023-2028)
  • Table 335. Taiwan Digital Genome, by Technology USD Million (2023-2028)
  • Table 336. Taiwan Digital Genome, by Product USD Million (2023-2028)
  • Table 337. Australia Digital Genome, by Application USD Million (2023-2028)
  • Table 338. Australia Digital Genome, by End Users USD Million (2023-2028)
  • Table 339. Australia Digital Genome, by Technology USD Million (2023-2028)
  • Table 340. Australia Digital Genome, by Product USD Million (2023-2028)
  • Table 341. Rest of Asia-Pacific Digital Genome, by Application USD Million (2023-2028)
  • Table 342. Rest of Asia-Pacific Digital Genome, by End Users USD Million (2023-2028)
  • Table 343. Rest of Asia-Pacific Digital Genome, by Technology USD Million (2023-2028)
  • Table 344. Rest of Asia-Pacific Digital Genome, by Product USD Million (2023-2028)
  • Table 345. Europe Digital Genome, by Country USD Million (2023-2028)
  • Table 346. Europe Digital Genome, by Application USD Million (2023-2028)
  • Table 347. Europe Digital Genome, by End Users USD Million (2023-2028)
  • Table 348. Europe Digital Genome, by Technology USD Million (2023-2028)
  • Table 349. Europe Digital Genome, by Product USD Million (2023-2028)
  • Table 350. Germany Digital Genome, by Application USD Million (2023-2028)
  • Table 351. Germany Digital Genome, by End Users USD Million (2023-2028)
  • Table 352. Germany Digital Genome, by Technology USD Million (2023-2028)
  • Table 353. Germany Digital Genome, by Product USD Million (2023-2028)
  • Table 354. France Digital Genome, by Application USD Million (2023-2028)
  • Table 355. France Digital Genome, by End Users USD Million (2023-2028)
  • Table 356. France Digital Genome, by Technology USD Million (2023-2028)
  • Table 357. France Digital Genome, by Product USD Million (2023-2028)
  • Table 358. Italy Digital Genome, by Application USD Million (2023-2028)
  • Table 359. Italy Digital Genome, by End Users USD Million (2023-2028)
  • Table 360. Italy Digital Genome, by Technology USD Million (2023-2028)
  • Table 361. Italy Digital Genome, by Product USD Million (2023-2028)
  • Table 362. United Kingdom Digital Genome, by Application USD Million (2023-2028)
  • Table 363. United Kingdom Digital Genome, by End Users USD Million (2023-2028)
  • Table 364. United Kingdom Digital Genome, by Technology USD Million (2023-2028)
  • Table 365. United Kingdom Digital Genome, by Product USD Million (2023-2028)
  • Table 366. Netherlands Digital Genome, by Application USD Million (2023-2028)
  • Table 367. Netherlands Digital Genome, by End Users USD Million (2023-2028)
  • Table 368. Netherlands Digital Genome, by Technology USD Million (2023-2028)
  • Table 369. Netherlands Digital Genome, by Product USD Million (2023-2028)
  • Table 370. Rest of Europe Digital Genome, by Application USD Million (2023-2028)
  • Table 371. Rest of Europe Digital Genome, by End Users USD Million (2023-2028)
  • Table 372. Rest of Europe Digital Genome, by Technology USD Million (2023-2028)
  • Table 373. Rest of Europe Digital Genome, by Product USD Million (2023-2028)
  • Table 374. MEA Digital Genome, by Country USD Million (2023-2028)
  • Table 375. MEA Digital Genome, by Application USD Million (2023-2028)
  • Table 376. MEA Digital Genome, by End Users USD Million (2023-2028)
  • Table 377. MEA Digital Genome, by Technology USD Million (2023-2028)
  • Table 378. MEA Digital Genome, by Product USD Million (2023-2028)
  • Table 379. Middle East Digital Genome, by Application USD Million (2023-2028)
  • Table 380. Middle East Digital Genome, by End Users USD Million (2023-2028)
  • Table 381. Middle East Digital Genome, by Technology USD Million (2023-2028)
  • Table 382. Middle East Digital Genome, by Product USD Million (2023-2028)
  • Table 383. Africa Digital Genome, by Application USD Million (2023-2028)
  • Table 384. Africa Digital Genome, by End Users USD Million (2023-2028)
  • Table 385. Africa Digital Genome, by Technology USD Million (2023-2028)
  • Table 386. Africa Digital Genome, by Product USD Million (2023-2028)
  • Table 387. North America Digital Genome, by Country USD Million (2023-2028)
  • Table 388. North America Digital Genome, by Application USD Million (2023-2028)
  • Table 389. North America Digital Genome, by End Users USD Million (2023-2028)
  • Table 390. North America Digital Genome, by Technology USD Million (2023-2028)
  • Table 391. North America Digital Genome, by Product USD Million (2023-2028)
  • Table 392. United States Digital Genome, by Application USD Million (2023-2028)
  • Table 393. United States Digital Genome, by End Users USD Million (2023-2028)
  • Table 394. United States Digital Genome, by Technology USD Million (2023-2028)
  • Table 395. United States Digital Genome, by Product USD Million (2023-2028)
  • Table 396. Canada Digital Genome, by Application USD Million (2023-2028)
  • Table 397. Canada Digital Genome, by End Users USD Million (2023-2028)
  • Table 398. Canada Digital Genome, by Technology USD Million (2023-2028)
  • Table 399. Canada Digital Genome, by Product USD Million (2023-2028)
  • Table 400. Mexico Digital Genome, by Application USD Million (2023-2028)
  • Table 401. Mexico Digital Genome, by End Users USD Million (2023-2028)
  • Table 402. Mexico Digital Genome, by Technology USD Million (2023-2028)
  • Table 403. Mexico Digital Genome, by Product USD Million (2023-2028)
  • Table 404. Digital Genome Sales: by Application(K Units)
  • Table 405. Digital Genome Sales Microbiology {Biological, Clinical, Industrial} , by Region K Units (2023-2028)
  • Table 406. Digital Genome Sales Reproductive & Genetic , by Region K Units (2023-2028)
  • Table 407. Digital Genome Sales Transplantation , by Region K Units (2023-2028)
  • Table 408. Digital Genome Sales Livestock and Agriculture , by Region K Units (2023-2028)
  • Table 409. Digital Genome Sales Forensics , by Region K Units (2023-2028)
  • Table 410. Digital Genome Sales Research and Development , by Region K Units (2023-2028)
  • Table 411. Digital Genome Sales: by End Users(K Units)
  • Table 412. Digital Genome Sales Diagnostics & Forensic Labs , by Region K Units (2023-2028)
  • Table 413. Digital Genome Sales Academic Research Institutes , by Region K Units (2023-2028)
  • Table 414. Digital Genome Sales Hospitals , by Region K Units (2023-2028)
  • Table 415. Digital Genome Sales Bio-Pharmaceutical Companies , by Region K Units (2023-2028)
  • Table 416. Digital Genome Sales: by Technology(K Units)
  • Table 417. Digital Genome Sales Sequencing , by Region K Units (2023-2028)
  • Table 418. Digital Genome Sales Microarray , by Region K Units (2023-2028)
  • Table 419. Digital Genome Sales PCR , by Region K Units (2023-2028)
  • Table 420. Digital Genome Sales: by Product(K Units)
  • Table 421. Digital Genome Sales Sequencing & Analyzer Instruments , by Region K Units (2023-2028)
  • Table 422. Digital Genome Sales DNA/RNA Analysis Kits , by Region K Units (2023-2028)
  • Table 423. Digital Genome Sales Sequencing Chips , by Region K Units (2023-2028)
  • Table 424. Digital Genome Sales Sequencing & Analysis Software , by Region K Units (2023-2028)
  • Table 425. Digital Genome Sales Sample Preparation Instruments , by Region K Units (2023-2028)
  • Table 426. South America Digital Genome Sales, by Country K Units (2023-2028)
  • Table 427. South America Digital Genome Sales, by Application K Units (2023-2028)
  • Table 428. South America Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 429. South America Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 430. South America Digital Genome Sales, by Product K Units (2023-2028)
  • Table 431. Brazil Digital Genome Sales, by Application K Units (2023-2028)
  • Table 432. Brazil Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 433. Brazil Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 434. Brazil Digital Genome Sales, by Product K Units (2023-2028)
  • Table 435. Argentina Digital Genome Sales, by Application K Units (2023-2028)
  • Table 436. Argentina Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 437. Argentina Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 438. Argentina Digital Genome Sales, by Product K Units (2023-2028)
  • Table 439. Rest of South America Digital Genome Sales, by Application K Units (2023-2028)
  • Table 440. Rest of South America Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 441. Rest of South America Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 442. Rest of South America Digital Genome Sales, by Product K Units (2023-2028)
  • Table 443. Asia Pacific Digital Genome Sales, by Country K Units (2023-2028)
  • Table 444. Asia Pacific Digital Genome Sales, by Application K Units (2023-2028)
  • Table 445. Asia Pacific Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 446. Asia Pacific Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 447. Asia Pacific Digital Genome Sales, by Product K Units (2023-2028)
  • Table 448. China Digital Genome Sales, by Application K Units (2023-2028)
  • Table 449. China Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 450. China Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 451. China Digital Genome Sales, by Product K Units (2023-2028)
  • Table 452. Japan Digital Genome Sales, by Application K Units (2023-2028)
  • Table 453. Japan Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 454. Japan Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 455. Japan Digital Genome Sales, by Product K Units (2023-2028)
  • Table 456. India Digital Genome Sales, by Application K Units (2023-2028)
  • Table 457. India Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 458. India Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 459. India Digital Genome Sales, by Product K Units (2023-2028)
  • Table 460. South Korea Digital Genome Sales, by Application K Units (2023-2028)
  • Table 461. South Korea Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 462. South Korea Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 463. South Korea Digital Genome Sales, by Product K Units (2023-2028)
  • Table 464. Taiwan Digital Genome Sales, by Application K Units (2023-2028)
  • Table 465. Taiwan Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 466. Taiwan Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 467. Taiwan Digital Genome Sales, by Product K Units (2023-2028)
  • Table 468. Australia Digital Genome Sales, by Application K Units (2023-2028)
  • Table 469. Australia Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 470. Australia Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 471. Australia Digital Genome Sales, by Product K Units (2023-2028)
  • Table 472. Rest of Asia-Pacific Digital Genome Sales, by Application K Units (2023-2028)
  • Table 473. Rest of Asia-Pacific Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 474. Rest of Asia-Pacific Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 475. Rest of Asia-Pacific Digital Genome Sales, by Product K Units (2023-2028)
  • Table 476. Europe Digital Genome Sales, by Country K Units (2023-2028)
  • Table 477. Europe Digital Genome Sales, by Application K Units (2023-2028)
  • Table 478. Europe Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 479. Europe Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 480. Europe Digital Genome Sales, by Product K Units (2023-2028)
  • Table 481. Germany Digital Genome Sales, by Application K Units (2023-2028)
  • Table 482. Germany Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 483. Germany Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 484. Germany Digital Genome Sales, by Product K Units (2023-2028)
  • Table 485. France Digital Genome Sales, by Application K Units (2023-2028)
  • Table 486. France Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 487. France Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 488. France Digital Genome Sales, by Product K Units (2023-2028)
  • Table 489. Italy Digital Genome Sales, by Application K Units (2023-2028)
  • Table 490. Italy Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 491. Italy Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 492. Italy Digital Genome Sales, by Product K Units (2023-2028)
  • Table 493. United Kingdom Digital Genome Sales, by Application K Units (2023-2028)
  • Table 494. United Kingdom Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 495. United Kingdom Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 496. United Kingdom Digital Genome Sales, by Product K Units (2023-2028)
  • Table 497. Netherlands Digital Genome Sales, by Application K Units (2023-2028)
  • Table 498. Netherlands Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 499. Netherlands Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 500. Netherlands Digital Genome Sales, by Product K Units (2023-2028)
  • Table 501. Rest of Europe Digital Genome Sales, by Application K Units (2023-2028)
  • Table 502. Rest of Europe Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 503. Rest of Europe Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 504. Rest of Europe Digital Genome Sales, by Product K Units (2023-2028)
  • Table 505. MEA Digital Genome Sales, by Country K Units (2023-2028)
  • Table 506. MEA Digital Genome Sales, by Application K Units (2023-2028)
  • Table 507. MEA Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 508. MEA Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 509. MEA Digital Genome Sales, by Product K Units (2023-2028)
  • Table 510. Middle East Digital Genome Sales, by Application K Units (2023-2028)
  • Table 511. Middle East Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 512. Middle East Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 513. Middle East Digital Genome Sales, by Product K Units (2023-2028)
  • Table 514. Africa Digital Genome Sales, by Application K Units (2023-2028)
  • Table 515. Africa Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 516. Africa Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 517. Africa Digital Genome Sales, by Product K Units (2023-2028)
  • Table 518. North America Digital Genome Sales, by Country K Units (2023-2028)
  • Table 519. North America Digital Genome Sales, by Application K Units (2023-2028)
  • Table 520. North America Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 521. North America Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 522. North America Digital Genome Sales, by Product K Units (2023-2028)
  • Table 523. United States Digital Genome Sales, by Application K Units (2023-2028)
  • Table 524. United States Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 525. United States Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 526. United States Digital Genome Sales, by Product K Units (2023-2028)
  • Table 527. Canada Digital Genome Sales, by Application K Units (2023-2028)
  • Table 528. Canada Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 529. Canada Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 530. Canada Digital Genome Sales, by Product K Units (2023-2028)
  • Table 531. Mexico Digital Genome Sales, by Application K Units (2023-2028)
  • Table 532. Mexico Digital Genome Sales, by End Users K Units (2023-2028)
  • Table 533. Mexico Digital Genome Sales, by Technology K Units (2023-2028)
  • Table 534. Mexico Digital Genome Sales, by Product K Units (2023-2028)
  • Table 535. Research Programs/Design for This Report
  • Table 536. Key Data Information from Secondary Sources
  • Table 537. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Digital Genome: by Application USD Million (2017-2022)
  • Figure 5. Global Digital Genome: by End Users USD Million (2017-2022)
  • Figure 6. Global Digital Genome: by Technology USD Million (2017-2022)
  • Figure 7. Global Digital Genome: by Product USD Million (2017-2022)
  • Figure 8. South America Digital Genome Share (%), by Country
  • Figure 9. Asia Pacific Digital Genome Share (%), by Country
  • Figure 10. Europe Digital Genome Share (%), by Country
  • Figure 11. MEA Digital Genome Share (%), by Country
  • Figure 12. North America Digital Genome Share (%), by Country
  • Figure 13. Global Digital Genome: by Application K Units (2017-2022)
  • Figure 14. Global Digital Genome: by End Users K Units (2017-2022)
  • Figure 15. Global Digital Genome: by Technology K Units (2017-2022)
  • Figure 16. Global Digital Genome: by Product K Units (2017-2022)
  • Figure 17. South America Digital Genome Share (%), by Country
  • Figure 18. Asia Pacific Digital Genome Share (%), by Country
  • Figure 19. Europe Digital Genome Share (%), by Country
  • Figure 20. MEA Digital Genome Share (%), by Country
  • Figure 21. North America Digital Genome Share (%), by Country
  • Figure 22. Global Digital Genome share by Players 2022 (%)
  • Figure 23. Global Digital Genome share by Players (Top 3) 2022(%)
  • Figure 24. Global Digital Genome share by Players (Top 5) 2022(%)
  • Figure 25. BCG Matrix for key Companies
  • Figure 26. Umbel (United States) Revenue, Net Income and Gross profit
  • Figure 27. Umbel (United States) Revenue: by Geography 2022
  • Figure 28. NanoString (United States) Revenue, Net Income and Gross profit
  • Figure 29. NanoString (United States) Revenue: by Geography 2022
  • Figure 30. BiogeniQ (Canada) Revenue, Net Income and Gross profit
  • Figure 31. BiogeniQ (Canada) Revenue: by Geography 2022
  • Figure 32. GenomeMe (Canada) Revenue, Net Income and Gross profit
  • Figure 33. GenomeMe (Canada) Revenue: by Geography 2022
  • Figure 34. Illumina (United States) Revenue, Net Income and Gross profit
  • Figure 35. Illumina (United States) Revenue: by Geography 2022
  • Figure 36. Agilent Technologies Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. Agilent Technologies Inc. (United States) Revenue: by Geography 2022
  • Figure 38. BioMerieux (France) Revenue, Net Income and Gross profit
  • Figure 39. BioMerieux (France) Revenue: by Geography 2022
  • Figure 40. Becton (United States) Revenue, Net Income and Gross profit
  • Figure 41. Becton (United States) Revenue: by Geography 2022
  • Figure 42. Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 43. Dickinson and Company (United States) Revenue: by Geography 2022
  • Figure 44. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 45. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2022
  • Figure 46. Global Digital Genome: by Application USD Million (2023-2028)
  • Figure 47. Global Digital Genome: by End Users USD Million (2023-2028)
  • Figure 48. Global Digital Genome: by Technology USD Million (2023-2028)
  • Figure 49. Global Digital Genome: by Product USD Million (2023-2028)
  • Figure 50. South America Digital Genome Share (%), by Country
  • Figure 51. Asia Pacific Digital Genome Share (%), by Country
  • Figure 52. Europe Digital Genome Share (%), by Country
  • Figure 53. MEA Digital Genome Share (%), by Country
  • Figure 54. North America Digital Genome Share (%), by Country
  • Figure 55. Global Digital Genome: by Application K Units (2023-2028)
  • Figure 56. Global Digital Genome: by End Users K Units (2023-2028)
  • Figure 57. Global Digital Genome: by Technology K Units (2023-2028)
  • Figure 58. Global Digital Genome: by Product K Units (2023-2028)
  • Figure 59. South America Digital Genome Share (%), by Country
  • Figure 60. Asia Pacific Digital Genome Share (%), by Country
  • Figure 61. Europe Digital Genome Share (%), by Country
  • Figure 62. MEA Digital Genome Share (%), by Country
  • Figure 63. North America Digital Genome Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Umbel (United States)
  • NanoString (United States)
  • BiogeniQ (Canada)
  • GenomeMe (Canada)
  • Illumina (United States)
  • Agilent Technologies Inc. (United States)
  • BioMerieux (France)
  • Becton (United States)
  • Dickinson and Company (United States)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
Additional players considered in the study are as follows:
GE Healthcare (United States) , Inscripta Inc. (United States) , NanoString Technologies, Inc. (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 245 Pages 95 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Digital Genome Quantitative research analysis
Global Digital Genome Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Digital Genome Market are Umbel (United States), NanoString (United States), BiogeniQ (Canada), GenomeMe (Canada), Illumina (United States), Agilent Technologies Inc. (United States), BioMerieux (France), Becton (United States), Dickinson and Company (United States) and F. Hoffmann-La Roche Ltd. (Switzerland) etc.
Microbiology {Biological, Clinical, Industrial} segment in Global market to hold robust market share owing to "Increasing Demand for the Open Access Web-Based Database of Medically Relevant Genomic Variants ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Digital Genome market throughout the forecasted period.

Know More About Global Digital Genome Report?

Have a Query? Click Here

Other Related Reports

Microalbumin Test Comprehensive Study by Type (Random Urine test, 24 hour urine test, Timed urine test), Application (Hospitals, Clinics, Diagnostics Laboratories, Others), End Users (Hospitals, Clin...
$ 3650
Artificial Blood Comprehensive Study by Type (Human Blood, Synthetic Blood, Animal Blood), Application (Cardiovascular diseases, Anemia, Organ transplant, Trauma, Others), End-use (Hospitals, Clinics...
$ 3350
Cryogenic Biobanking Services Comprehensive Study by Type (Ice Machines, Freezers, Alarms And Monitoring System, Refrigerators, Cryogenic Storage Systems, Accessories), Application (Biobaking, Regene...
$ 3750
Gastritis Treatment Comprehensive Study by Type (Acid Blocking Medications, Acid Reducing Medications, Antacids, Antibiotics, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, On...
$ 3650
Medical Wellness Comprehensive Study by Type (Complementary and Alternative Medicine, Beauty Care and Anti-Aging, Preventative & Personalized Medicine and Public Health, Healthy Eating, Nutrition & W...
$ 3450
Vision Care Comprehensive Study by Type (Eye Glasses {Single Vision Eyeglasses, Bifocal Eyeglasses, Progressive Eyeglasses}, Contact Lens {Personalized/Custom, Specific Care, Single Vision, Progressi...
$ 3750